Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Multicentre Trial for the Use of 5-ALA Paediatric Patients With High Grade Brain Tumours

NCT06678867 is registered in ClinicalTrials.gov with University College, London as lead sponsor.

NCT NCT06678867
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06678867 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Multicentre Trial for the Use of 5-ALA Paediatric Patients With High Grade Brain Tumours
Lead sponsor
University College, London
Phase
Phase 2
Overall status
Not yet recruiting
Start date
March 25, 2025
Completion date
December 30, 2026
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain tumor